These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21426549)

  • 21. What can the World Health Organization learn from EU lessons in civil society engagement and participation for health?
    Battams S
    Int J Health Serv; 2014; 44(4):805-16. PubMed ID: 25626229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
    Jaillon P
    Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Union research and innovation perspectives on biotechnology.
    Cichocka D; Claxton J; Economidis I; Högel J; Venturi P; Aguilar A
    J Biotechnol; 2011 Dec; 156(4):382-91. PubMed ID: 21745504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "It's About the Idea Hitting the Bull's Eye": How Aid Effectiveness Can Catalyse the Scale-up of Health Innovations.
    Wickremasinghe D; Gautham M; Umar N; Berhanu D; Schellenberg J; Spicer N
    Int J Health Policy Manag; 2018 Aug; 7(8):718-727. PubMed ID: 30078292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Civil society organisations and public health research--evidence from eight European union new member states.
    Knabe A; McCarthy M
    Cent Eur J Public Health; 2012 Dec; 20(4):287-93. PubMed ID: 23441396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives for food research and European collaboration in the European Research Area and the new Framework Programme.
    Breslin L
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4 Suppl):16-9. PubMed ID: 11894746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shaping science policy in Europe.
    Celis JE; Gago JM
    Mol Oncol; 2014 May; 8(3):447-57. PubMed ID: 24726457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing public-health research priorities in Europe.
    McCarthy M; Harvey G; Conceição C; la Torre G; Gulis G
    Health Res Policy Syst; 2009 Jul; 7():17. PubMed ID: 19602239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracking uptake of innovations from the European Union Public Health Programme.
    Voss M; Alexanderson K; McCarthy M
    Eur J Public Health; 2013 Nov; 23 Suppl 2():19-24. PubMed ID: 24189791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Civil society participation in global public private partnerships for health.
    Storeng KT; de Bengy Puyvallée A
    Health Policy Plan; 2018 Oct; 33(8):928-936. PubMed ID: 30165606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Commission activities in eHealth.
    Olsson S; Lymberis A; Whitehouse D
    Int J Circumpolar Health; 2004 Dec; 63(4):310-6. PubMed ID: 15709306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.
    Eggersdorfer M; Bird JK
    World Rev Nutr Diet; 2016; 115():224-32. PubMed ID: 27198563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Global Fund and the re-configuration and re-emergence of 'civil society': widening or closing the democratic deficit?
    Kapilashrami A; O'Brien O
    Glob Public Health; 2012; 7(5):437-51. PubMed ID: 22239445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assuring health coverage for all in India.
    Patel V; Parikh R; Nandraj S; Balasubramaniam P; Narayan K; Paul VK; Kumar AK; Chatterjee M; Reddy KS
    Lancet; 2015 Dec; 386(10011):2422-35. PubMed ID: 26700532
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.